Releviate™ Therapeutics, a bio-pharmaceutical company addressing the needs of patients suffering from chronic pain, signs an exclusive license for two patent pending human monoclonal antibodies developed by researchers at the University of California, Riverside and [...]
This study will assess the effect of incorporating a tonal exercise device into clinical and chiropractic care for lower back pain. Read more.
Women with high levels of posttraumatic stress disorder symptoms, anger, poor sleep, and low social support who experience acute pain may maintain elevated pain for 3 months. Read more.
AAPM member Paul Glare, MD, discusses the work of the multidisciplinary unit at Pain Management Research Institute (PMRI), University of Sydney, Australia, that focuses on the medical, psychological, and philosophical aspects of pain. Read more.
The following is a prospective, multicenter, open-label, post-market study to evaluate the efficacy and energy use of a low energy DTM™ (DTM-LE) SCS therapy for pain relief. Read more.
© American Academy of Pain Medicine. All Rights Reserved | Privacy Policy | Media Resources
American Academy of Pain Medicine (AAPM) is a nonprofit 501(c)(6) tax-exempt organization.
